341 related articles for article (PubMed ID: 27453043)
1. A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.
Srivas R; Shen JP; Yang CC; Sun SM; Li J; Gross AM; Jensen J; Licon K; Bojorquez-Gomez A; Klepper K; Huang J; Pekin D; Xu JL; Yeerna H; Sivaganesh V; Kollenstart L; van Attikum H; Aza-Blanc P; Sobol RW; Ideker T
Mol Cell; 2016 Aug; 63(3):514-25. PubMed ID: 27453043
[TBL] [Abstract][Full Text] [Related]
2. Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibition.
Shen JP; Srivas R; Gross A; Li J; Jaehnig EJ; Sun SM; Bojorquez-Gomez A; Licon K; Sivaganesh V; Xu JL; Klepper K; Yeerna H; Pekin D; Qiu CP; van Attikum H; Sobol RW; Ideker T
Oncotarget; 2015 Nov; 6(34):35755-69. PubMed ID: 26437225
[TBL] [Abstract][Full Text] [Related]
3. A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.
Reid RJ; Du X; Sunjevaric I; Rayannavar V; Dittmar J; Bryant E; Maurer M; Rothstein R
Genetics; 2016 Oct; 204(2):807-819. PubMed ID: 27558135
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Lethal Interactions of RECQ Helicases.
Datta A; Dhar S; Awate S; Brosh RM
Trends Cancer; 2021 Feb; 7(2):146-161. PubMed ID: 33041245
[TBL] [Abstract][Full Text] [Related]
5. Integrating transcriptional and protein interaction networks to prioritize condition-specific master regulators.
Padi M; Quackenbush J
BMC Syst Biol; 2015 Nov; 9():80. PubMed ID: 26576632
[TBL] [Abstract][Full Text] [Related]
6. Saccharomyces cerevisiae genetics predicts candidate therapeutic genetic interactions at the mammalian replication fork.
van Pel DM; Stirling PC; Minaker SW; Sipahimalani P; Hieter P
G3 (Bethesda); 2013 Feb; 3(2):273-82. PubMed ID: 23390603
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.
Caruso S; Calatayud AL; Pilet J; La Bella T; Rekik S; Imbeaud S; Letouzé E; Meunier L; Bayard Q; Rohr-Udilova N; Péneau C; Grasl-Kraupp B; de Koning L; Ouine B; Bioulac-Sage P; Couchy G; Calderaro J; Nault JC; Zucman-Rossi J; Rebouissou S
Gastroenterology; 2019 Sep; 157(3):760-776. PubMed ID: 31063779
[TBL] [Abstract][Full Text] [Related]
8. Synthetic lethal vulnerabilities of cancer.
Fece de la Cruz F; Gapp BV; Nijman SM
Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
[TBL] [Abstract][Full Text] [Related]
9. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
[TBL] [Abstract][Full Text] [Related]
11. Human RecQL4 helicase plays multifaceted roles in the genomic stability of normal and cancer cells.
Mo D; Zhao Y; Balajee AS
Cancer Lett; 2018 Jan; 413():1-10. PubMed ID: 29080750
[TBL] [Abstract][Full Text] [Related]
12. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
Lotito L; Russo A; Bueno S; Chillemi G; Fogli MV; Capranico G
Eur J Pharmacol; 2009 Jan; 603(1-3):29-36. PubMed ID: 19094980
[TBL] [Abstract][Full Text] [Related]
13. Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Topatana W; Juengpanich S; Li S; Cao J; Hu J; Lee J; Suliyanto K; Ma D; Zhang B; Chen M; Cai X
J Hematol Oncol; 2020 Sep; 13(1):118. PubMed ID: 32883316
[TBL] [Abstract][Full Text] [Related]
14. Mapping the Synthetic Dosage Lethality Network of
Zimmermann C; Garcia I; Omerzu M; Chymkowitch P; Zhang B; Enserink JM
G3 (Bethesda); 2017 Jun; 7(6):1753-1766. PubMed ID: 28428242
[TBL] [Abstract][Full Text] [Related]
15. Diverse functions of spindle assembly checkpoint genes in Saccharomyces cerevisiae.
Daniel JA; Keyes BE; Ng YP; Freeman CO; Burke DJ
Genetics; 2006 Jan; 172(1):53-65. PubMed ID: 16157669
[TBL] [Abstract][Full Text] [Related]
16. Aurora kinase A, a synthetic lethal target for precision cancer medicine.
Mou PK; Yang EJ; Shi C; Ren G; Tao S; Shim JS
Exp Mol Med; 2021 May; 53(5):835-847. PubMed ID: 34050264
[TBL] [Abstract][Full Text] [Related]
17. The isomerase Rrd1 mediates rapid loss of the Sgs1 helicase in response to rapamycin.
Marrakchi R; Chouchani C; Cherif M; Boudabbous A; Ramotar D
Biochem Cell Biol; 2011 Jun; 89(3):332-40. PubMed ID: 21639830
[TBL] [Abstract][Full Text] [Related]
18. The synthetic genetic interaction network reveals small molecules that target specific pathways in Sacchromyces cerevisiae.
Tamble CM; St Onge RP; Giaever G; Nislow C; Williams AG; Stuart JM; Lokey RS
Mol Biosyst; 2011 Jun; 7(6):2019-30. PubMed ID: 21487606
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Network Basis of Negative Genetic Interactions in Saccharomyces cerevisiae with Integrated Biological Networks and Triplet Motif Analysis.
Ignatius Pang CN; Goel A; Wilkins MR
J Proteome Res; 2018 Mar; 17(3):1014-1030. PubMed ID: 29392949
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Lethality: From Research to Precision Cancer Nanomedicine.
Gupta A; Ahmad A; Dar AI; Khan R
Curr Cancer Drug Targets; 2018; 18(4):337-346. PubMed ID: 28669337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
